Robbins Headache Clinic Blog
FDA Grants First Approvals for Generic Versions of Lyrica
Nine drug companies have received approval for the first generic versions of Lyrica (pregabalin), the U.S. Food and Drug Administration announced. Read more here.
Nearly 20% of Migraineurs Use Opioids for Migraine
Read more here.
How Does Gender Bias Affect the Headache Field?
Read more here.
Telemedicine Migraine Consults are as Effective as In-Office Visits
Migraine patients fared as well when managed for a year by telemedicine as did patients managed by a 12-month series of routine office visits in a single-center, randomized trial with 40 patients Read more here.
Acute Risk of Migraine Linked to White Light Exposure
The level of exposure to white light is associated with acute risk of headache onset in patients with episodic migraine, according to research presented at the annual meeting of the American Headache Society. The data raise the question of whether modifying light...
New Daily Persistent Headache: A Systemic Review on an Engimatic Disorder
New daily persistent headache (NDPH) presents with a sudden onset headache which continues without remission within 24?h. Although rare, NDPH is important because it is one of the most treatment refractory primary headache disorders and can be highly disabling to the...
New Drug Relieves Acute Migraine in Clinical Trial
People who experience acute migraine may soon find relief in a new treatment. The results of a clinical trial of a novel drug revealed that it can eliminate head pain and reduce other symptoms of migraine. Read more here.
Why Newer Migraine Blockers Fail Some Patients
Research in an animal model of headache suggests that different underlying mechanisms at work in migraine may explain why some calcitonin gene-related peptide inhibitors, such as fremanezumab, may not work for everyone. Read more here.
High School Start Time and Migraine
In this cross-sectional observational study with 256 students, researchers explored whether a later high school start time was correlated with lower migraine frequency in high school students with migraine. Using social media, participants were recruited nationally....
CGRP AND SIDE EFFECTS: LETTER IN ‘HEADACHE”
This is a new letter to the editor that I wrote, in the journal Headache; these newer CGRP meds are marvelous for many patients, but the true side effect profile is just evolving: (LETTER FROM THE JOURNAL HEADACHE, JULY, 2019: LAWRENCE ROBBINS,M.D.) Erenumab, the...